Status:
UNKNOWN
Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Neoplasm Metastasis
Eligibility:
All Genders
18-100 years
Brief Summary
The investigators recently published 2 phase II trials on the use of helical tomotherapy for oligometastatic colorectal cancer \[1,2\]. Despite a dose increase from 40 to 50 Gy, delivered in 2 weeks t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with metastatic cancer from any primary origin and no more than 5 metastases on CT--scan
- Primary tumor treated with curative intention (surgery, radiotherapy, chemoradiotherapy)
- Functional liver volume \> 1000cc in case of liver metastases and a lung diffusion capacity for carbon monoxide (DLCO) of \> 30% if lung mets
- No Child B or C liver cirrhosis
- No systemic treatment within 1 month before initiation of radiotherapy
- No contra-indications for radiation of all metastatic disease (= no violation of constraints of organs at risk (OAR))
- No metastases from another carcinoma
- Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
- Age \> 18 years
Exclusion
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02228356
Start Date
June 1 2012
Last Update
May 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel Radiotherapie dienst
Jette, Brussels Capital, Belgium, 1090